Barbeau, Dominique J. http://orcid.org/0000-0001-6493-5022
Martin, Judith M. http://orcid.org/0000-0001-9456-1770
Carney, Emily
Dougherty, Emily
Doyle, Joshua D.
Dermody, Terence S.
Hoberman, Alejandro
Williams, John V.
Michaels, Marian G.
Alcorn, John F. http://orcid.org/0000-0001-5997-7711
Paul Duprex, W. http://orcid.org/0000-0003-1716-6376
McElroy, Anita K. http://orcid.org/0000-0001-6764-7536
Funding for this research was provided by:
Burroughs Wellcome Fund (1013362.02)
RK Mellon Foundation, University of Pittsburgh Center for Vaccine Researach and Henry L Hillman Foundation.
no relevant funding- it won't permit me to check this button
Article History
Received: 19 March 2022
Accepted: 22 June 2022
First Online: 6 July 2022
Competing interests
: J.M.M. and A.H. receive funding from NIH/NIAID (UM1AI148452) and are investigators for the adult mRNA1273 and Ad26.COV2.S phase 3 vaccine studies. J.V.W. serves on the Scientific Advisory Board of Quidel and an Independent Data Monitoring Committee for GlaxoSmithKline, neither related to the present work. All authors declare no competing non-financial interests.